 | • レポートコード：MRC2012A2570 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、嚢胞性線維症治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。嚢胞性線維症治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Actavis、Arcturus Therapeutics、Novartis、F. Hoffmann-La Roche、Anthera Pharmaceuticals、Gilead Sciences、Chiesi Farmaceutici、Abbott、Vertex Pharmaceuticals、Boehringer Ingelheim、Merck Sharp & Dohme、PharmaSwiss、Corbus Pharmaceuticals、Proteostasis Therapeutics、Neovii Biotech、Johnson & Johnson、Genzyme、Pharmaxis、Novo Nordisk、Insmed、PTC Therapeutics、United Medical、Venus Remedies、 ・地域別グローバル市場分析 2015年-2020年 ・嚢胞性線維症治療薬の北米市場（アメリカ、カナダ、メキシコ） ・嚢胞性線維症治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・嚢胞性線維症治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・嚢胞性線維症治療薬の南米市場（ブラジル、アルゼンチン） ・嚢胞性線維症治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cystic Fibrosis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cystic Fibrosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cystic Fibrosis Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cystic Fibrosis Drugs market has been segmented into
Oral
Injection
By Application, Cystic Fibrosis Drugs has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cystic Fibrosis Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Cystic Fibrosis Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cystic Fibrosis Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Cystic Fibrosis Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cystic Fibrosis Drugs Market Share Analysis
Cystic Fibrosis Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cystic Fibrosis Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cystic Fibrosis Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Cystic Fibrosis Drugs are:
Actavis
Arcturus Therapeutics
Novartis
F. Hoffmann-La Roche
Anthera Pharmaceuticals
Gilead Sciences
Chiesi Farmaceutici
Abbott
Vertex Pharmaceuticals
Boehringer Ingelheim
Merck Sharp & Dohme
PharmaSwiss
Corbus Pharmaceuticals
Proteostasis Therapeutics
Neovii Biotech
Johnson & Johnson
Genzyme
Pharmaxis
Novo Nordisk
Insmed
PTC Therapeutics
United Medical
Venus Remedies
Among other players domestic and global, Cystic Fibrosis Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cystic Fibrosis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cystic Fibrosis Drugs, with price, sales, revenue and global market share of Cystic Fibrosis Drugs in 2018 and 2019.
Chapter 3, the Cystic Fibrosis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cystic Fibrosis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cystic Fibrosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cystic Fibrosis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cystic Fibrosis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cystic Fibrosis Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Cystic Fibrosis Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Cystic Fibrosis Drugs Market
1.4.1 Global Cystic Fibrosis Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Actavis
2.1.1 Actavis Details
2.1.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Actavis SWOT Analysis
2.1.4 Actavis Product and Services
2.1.5 Actavis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arcturus Therapeutics
2.2.1 Arcturus Therapeutics Details
2.2.2 Arcturus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arcturus Therapeutics SWOT Analysis
2.2.4 Arcturus Therapeutics Product and Services
2.2.5 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Anthera Pharmaceuticals
2.5.1 Anthera Pharmaceuticals Details
2.5.2 Anthera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Anthera Pharmaceuticals SWOT Analysis
2.5.4 Anthera Pharmaceuticals Product and Services
2.5.5 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gilead Sciences SWOT Analysis
2.6.4 Gilead Sciences Product and Services
2.6.5 Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chiesi Farmaceutici
2.7.1 Chiesi Farmaceutici Details
2.7.2 Chiesi Farmaceutici Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Chiesi Farmaceutici SWOT Analysis
2.7.4 Chiesi Farmaceutici Product and Services
2.7.5 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott SWOT Analysis
2.8.4 Abbott Product and Services
2.8.5 Abbott Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Vertex Pharmaceuticals
2.9.1 Vertex Pharmaceuticals Details
2.9.2 Vertex Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Vertex Pharmaceuticals SWOT Analysis
2.9.4 Vertex Pharmaceuticals Product and Services
2.9.5 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim SWOT Analysis
2.10.4 Boehringer Ingelheim Product and Services
2.10.5 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck Sharp & Dohme
2.11.1 Merck Sharp & Dohme Details
2.11.2 Merck Sharp & Dohme Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck Sharp & Dohme SWOT Analysis
2.11.4 Merck Sharp & Dohme Product and Services
2.11.5 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 PharmaSwiss
2.12.1 PharmaSwiss Details
2.12.2 PharmaSwiss Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 PharmaSwiss SWOT Analysis
2.12.4 PharmaSwiss Product and Services
2.12.5 PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Corbus Pharmaceuticals
2.13.1 Corbus Pharmaceuticals Details
2.13.2 Corbus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Corbus Pharmaceuticals SWOT Analysis
2.13.4 Corbus Pharmaceuticals Product and Services
2.13.5 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Proteostasis Therapeutics
2.14.1 Proteostasis Therapeutics Details
2.14.2 Proteostasis Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Proteostasis Therapeutics SWOT Analysis
2.14.4 Proteostasis Therapeutics Product and Services
2.14.5 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Neovii Biotech
2.15.1 Neovii Biotech Details
2.15.2 Neovii Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Neovii Biotech SWOT Analysis
2.15.4 Neovii Biotech Product and Services
2.15.5 Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Johnson & Johnson SWOT Analysis
2.16.4 Johnson & Johnson Product and Services
2.16.5 Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Genzyme
2.17.1 Genzyme Details
2.17.2 Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Genzyme SWOT Analysis
2.17.4 Genzyme Product and Services
2.17.5 Genzyme Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Pharmaxis
2.18.1 Pharmaxis Details
2.18.2 Pharmaxis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Pharmaxis SWOT Analysis
2.18.4 Pharmaxis Product and Services
2.18.5 Pharmaxis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Novo Nordisk
2.19.1 Novo Nordisk Details
2.19.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Novo Nordisk SWOT Analysis
2.19.4 Novo Nordisk Product and Services
2.19.5 Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Insmed
2.20.1 Insmed Details
2.20.2 Insmed Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Insmed SWOT Analysis
2.20.4 Insmed Product and Services
2.20.5 Insmed Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 PTC Therapeutics
2.21.1 PTC Therapeutics Details
2.21.2 PTC Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 PTC Therapeutics SWOT Analysis
2.21.4 PTC Therapeutics Product and Services
2.21.5 PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 United Medical
2.22.1 United Medical Details
2.22.2 United Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 United Medical SWOT Analysis
2.22.4 United Medical Product and Services
2.22.5 United Medical Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Venus Remedies
2.23.1 Venus Remedies Details
2.23.2 Venus Remedies Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Venus Remedies SWOT Analysis
2.23.4 Venus Remedies Product and Services
2.23.5 Venus Remedies Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cystic Fibrosis Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cystic Fibrosis Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Cystic Fibrosis Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cystic Fibrosis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cystic Fibrosis Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
4.5 South America Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cystic Fibrosis Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Cystic Fibrosis Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Cystic Fibrosis Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cystic Fibrosis Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Cystic Fibrosis Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cystic Fibrosis Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
6.3 UK Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
6.4 France Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cystic Fibrosis Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cystic Fibrosis Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cystic Fibrosis Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7.5 India Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cystic Fibrosis Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Cystic Fibrosis Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Cystic Fibrosis Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cystic Fibrosis Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cystic Fibrosis Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cystic Fibrosis Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cystic Fibrosis Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Cystic Fibrosis Drugs Price by Type (2015-2020)
11 Global Cystic Fibrosis Drugs Market Segment by Application
11.1 Global Cystic Fibrosis Drugs Sales Market Share by Application (2015-2020)
11.2 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Cystic Fibrosis Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cystic Fibrosis Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Cystic Fibrosis Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Cystic Fibrosis Drugs Market Forecast (2021-2025)
12.2.2 Europe Cystic Fibrosis Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cystic Fibrosis Drugs Market Forecast (2021-2025)
12.2.4 South America Cystic Fibrosis Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cystic Fibrosis Drugs Market Forecast (2021-2025)
12.3 Cystic Fibrosis Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Cystic Fibrosis Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Cystic Fibrosis Drugs Market Share Forecast by Type (2021-2025)
12.4 Cystic Fibrosis Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Cystic Fibrosis Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Cystic Fibrosis Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cystic Fibrosis Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cystic Fibrosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cystic Fibrosis Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Actavis Basic Information, Manufacturing Base and Competitors
Table 8. Actavis Cystic Fibrosis Drugs Major Business
Table 9. Actavis Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Actavis SWOT Analysis
Table 11. Actavis Cystic Fibrosis Drugs Product and Services
Table 12. Actavis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Arcturus Therapeutics Cystic Fibrosis Drugs Major Business
Table 15. Arcturus Therapeutics Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Arcturus Therapeutics SWOT Analysis
Table 17. Arcturus Therapeutics Cystic Fibrosis Drugs Product and Services
Table 18. Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Cystic Fibrosis Drugs Major Business
Table 21. Novartis Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Cystic Fibrosis Drugs Product and Services
Table 24. Novartis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 26. F. Hoffmann-La Roche Cystic Fibrosis Drugs Major Business
Table 27. F. Hoffmann-La Roche Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 28. F. Hoffmann-La Roche SWOT Analysis
Table 29. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product and Services
Table 30. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Anthera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Anthera Pharmaceuticals Cystic Fibrosis Drugs Major Business
Table 33. Anthera Pharmaceuticals Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Anthera Pharmaceuticals SWOT Analysis
Table 35. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product and Services
Table 36. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 38. Gilead Sciences Cystic Fibrosis Drugs Major Business
Table 39. Gilead Sciences Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Gilead Sciences SWOT Analysis
Table 41. Gilead Sciences Cystic Fibrosis Drugs Product and Services
Table 42. Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 44. Chiesi Farmaceutici Cystic Fibrosis Drugs Major Business
Table 45. Chiesi Farmaceutici Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Chiesi Farmaceutici SWOT Analysis
Table 47. Chiesi Farmaceutici Cystic Fibrosis Drugs Product and Services
Table 48. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Abbott Basic Information, Manufacturing Base and Competitors
Table 50. Abbott Cystic Fibrosis Drugs Major Business
Table 51. Abbott Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Abbott SWOT Analysis
Table 53. Abbott Cystic Fibrosis Drugs Product and Services
Table 54. Abbott Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Vertex Pharmaceuticals Cystic Fibrosis Drugs Major Business
Table 57. Vertex Pharmaceuticals Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Vertex Pharmaceuticals SWOT Analysis
Table 59. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product and Services
Table 60. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Cystic Fibrosis Drugs Major Business
Table 63. Boehringer Ingelheim Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Boehringer Ingelheim SWOT Analysis
Table 65. Boehringer Ingelheim Cystic Fibrosis Drugs Product and Services
Table 66. Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 68. Merck Sharp & Dohme Cystic Fibrosis Drugs Major Business
Table 69. Merck Sharp & Dohme Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Merck Sharp & Dohme SWOT Analysis
Table 71. Merck Sharp & Dohme Cystic Fibrosis Drugs Product and Services
Table 72. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. PharmaSwiss Basic Information, Manufacturing Base and Competitors
Table 74. PharmaSwiss Cystic Fibrosis Drugs Major Business
Table 75. PharmaSwiss Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 76. PharmaSwiss SWOT Analysis
Table 77. PharmaSwiss Cystic Fibrosis Drugs Product and Services
Table 78. PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Corbus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Corbus Pharmaceuticals Cystic Fibrosis Drugs Major Business
Table 81. Corbus Pharmaceuticals Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Corbus Pharmaceuticals SWOT Analysis
Table 83. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product and Services
Table 84. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Proteostasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Proteostasis Therapeutics Cystic Fibrosis Drugs Major Business
Table 87. Proteostasis Therapeutics Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Proteostasis Therapeutics SWOT Analysis
Table 89. Proteostasis Therapeutics Cystic Fibrosis Drugs Product and Services
Table 90. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Neovii Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Neovii Biotech Cystic Fibrosis Drugs Major Business
Table 93. Neovii Biotech Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Neovii Biotech SWOT Analysis
Table 95. Neovii Biotech Cystic Fibrosis Drugs Product and Services
Table 96. Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Cystic Fibrosis Drugs Major Business
Table 99. Johnson & Johnson Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Johnson & Johnson SWOT Analysis
Table 101. Johnson & Johnson Cystic Fibrosis Drugs Product and Services
Table 102. Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Genzyme Basic Information, Manufacturing Base and Competitors
Table 104. Genzyme Cystic Fibrosis Drugs Major Business
Table 105. Genzyme Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Genzyme SWOT Analysis
Table 107. Genzyme Cystic Fibrosis Drugs Product and Services
Table 108. Genzyme Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Pharmaxis Cystic Fibrosis Drugs Type and Application
Table 110. Pharmaxis Cystic Fibrosis Drugs Major Business
Table 111. Pharmaxis Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Pharmaxis SWOT Analysis
Table 113. Pharmaxis Cystic Fibrosis Drugs Product and Services
Table 114. Pharmaxis Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 116. Novo Nordisk Cystic Fibrosis Drugs Major Business
Table 117. Novo Nordisk Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Novo Nordisk SWOT Analysis
Table 119. Novo Nordisk Cystic Fibrosis Drugs Product and Services
Table 120. Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Insmed Basic Information, Manufacturing Base and Competitors
Table 122. Insmed Cystic Fibrosis Drugs Major Business
Table 123. Insmed Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 124. Insmed SWOT Analysis
Table 125. Insmed Cystic Fibrosis Drugs Product and Services
Table 126. Insmed Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. PTC Therapeutics Cystic Fibrosis Drugs Major Business
Table 129. PTC Therapeutics Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 130. PTC Therapeutics SWOT Analysis
Table 131. PTC Therapeutics Cystic Fibrosis Drugs Product and Services
Table 132. PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. United Medical Basic Information, Manufacturing Base and Competitors
Table 134. United Medical Cystic Fibrosis Drugs Major Business
Table 135. United Medical Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 136. United Medical SWOT Analysis
Table 137. United Medical Cystic Fibrosis Drugs Product and Services
Table 138. United Medical Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Venus Remedies Basic Information, Manufacturing Base and Competitors
Table 140. Venus Remedies Cystic Fibrosis Drugs Major Business
Table 141. Venus Remedies Cystic Fibrosis Drugs Total Revenue (USD Million) (2017-2018)
Table 142. Venus Remedies SWOT Analysis
Table 143. Venus Remedies Cystic Fibrosis Drugs Product and Services
Table 144. Venus Remedies Cystic Fibrosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. Global Cystic Fibrosis Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 146. Global Cystic Fibrosis Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 147. Global Cystic Fibrosis Drugs Sales by Regions (2015-2020) (K Pcs)
Table 148. Global Cystic Fibrosis Drugs Sales Market Share by Regions (2015-2020)
Table 149. Global Cystic Fibrosis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 150. North America Cystic Fibrosis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 151. North America Cystic Fibrosis Drugs Sales Market Share by Countries (2015-2020)
Table 152. North America Cystic Fibrosis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 153. North America Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020)
Table 154. Europe Cystic Fibrosis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 155. Europe Cystic Fibrosis Drugs Sales Market Share by Countries (2015-2020)
Table 156. Europe Cystic Fibrosis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 157. Asia-Pacific Cystic Fibrosis Drugs Sales by Regions (2015-2020) (K Pcs)
Table 158. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share by Regions (2015-2020)
Table 159. Asia-Pacific Cystic Fibrosis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 160. South America Cystic Fibrosis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 161. South America Cystic Fibrosis Drugs Sales Market Share by Countries (2015-2020)
Table 162. South America Cystic Fibrosis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 163. South America Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020)
Table 164. Middle East & Africa Cystic Fibrosis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 165. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Countries (2015-2020)
Table 166. Middle East & Africa Cystic Fibrosis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 167. Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020)
Table 168. Global Cystic Fibrosis Drugs Sales by Type (2015-2020) (K Pcs)
Table 169. Global Cystic Fibrosis Drugs Sales Share by Type (2015-2020)
Table 170. Global Cystic Fibrosis Drugs Revenue by Type (2015-2020) (USD Million)
Table 171. Global Cystic Fibrosis Drugs Revenue Share by Type (2015-2020)
Table 172. Global Cystic Fibrosis Drugs Sales by Application (2015-2020) (K Pcs)
Table 173. Global Cystic Fibrosis Drugs Sales Share by Application (2015-2020)
Table 174. Global Cystic Fibrosis Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 175. Global Cystic Fibrosis Drugs Market Share Forecast by Regions (2021-2025)
Table 176. Global Cystic Fibrosis Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 177. Global Cystic Fibrosis Drugs Market Share Forecast by Type (2021-2025)
Table 178. Global Cystic Fibrosis Drugs Sales Forecast by Application (2021-2025)
Table 179. Global Cystic Fibrosis Drugs Market Share Forecast by Application (2021-2025)
Table 180. Direct Channel Pros & Cons
Table 181. Indirect Channel Pros & Cons
Table 182. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cystic Fibrosis Drugs Picture
Figure 2. Global Sales Market Share of Cystic Fibrosis Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Cystic Fibrosis Drugs Sales Market Share by Application in 2018
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Cystic Fibrosis Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Cystic Fibrosis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Cystic Fibrosis Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Cystic Fibrosis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Cystic Fibrosis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 35. Global Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Cystic Fibrosis Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Cystic Fibrosis Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Cystic Fibrosis Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Cystic Fibrosis Drugs Sales Market Share by Countries in 2018
Figure 46. North America Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Cystic Fibrosis Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Mexico Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Europe Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Cystic Fibrosis Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. UK Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. France Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Asia-Pacific Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Cystic Fibrosis Drugs Revenue Market Share by Regions 2019
Figure 62. China Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Korea Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. India Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Southeast Asia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. South America Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Cystic Fibrosis Drugs Sales Market Share by Countries in 2019
Figure 69. South America Cystic Fibrosis Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Argentina Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Middle East and Africa Cystic Fibrosis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Egypt Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Turkey Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. South Africa Cystic Fibrosis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Global Cystic Fibrosis Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 81. Global Cystic Fibrosis Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Cystic Fibrosis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 83. Europe Sales Cystic Fibrosis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 84. Asia-Pacific Sales Cystic Fibrosis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. South America Sales Cystic Fibrosis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Middle East & Africa Sales Cystic Fibrosis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
嚢胞性線維症（ムコビスコイドーシス）検査の世界市場（～2026年） Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thi…- 呼吸器系治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Respiratory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Drugs market re…
- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…
- 皮膚線維症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous Fibrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 肝線維症治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Liver Fibrosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…